BTMD vs. ADTH, DCRD, OPAL, TLRY, CRON, USNA, CGC, MNMD, ACB, and CDXC
Should you be buying biote stock or one of its competitors? The main competitors of biote include AdTheorent (ADTH), Decarbonization Plus Acquisition Co. IV (DCRD), OPAL Fuels (OPAL), Tilray (TLRY), Cronos Group (CRON), USANA Health Sciences (USNA), Canopy Growth (CGC), Mind Medicine (MindMed) (MNMD), Aurora Cannabis (ACB), and ChromaDex (CDXC).
biote (NASDAQ:BTMD) and AdTheorent (NASDAQ:ADTH) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, analyst recommendations, community ranking, media sentiment, profitability, institutional ownership, risk, dividends and earnings.
AdTheorent received 13 more outperform votes than biote when rated by MarketBeat users. However, 100.00% of users gave biote an outperform vote while only 61.90% of users gave AdTheorent an outperform vote.
biote has a beta of 0.87, indicating that its share price is 13% less volatile than the S&P 500. Comparatively, AdTheorent has a beta of 1.21, indicating that its share price is 21% more volatile than the S&P 500.
In the previous week, AdTheorent had 1 more articles in the media than biote. MarketBeat recorded 2 mentions for AdTheorent and 1 mentions for biote. biote's average media sentiment score of 1.89 beat AdTheorent's score of 0.44 indicating that biote is being referred to more favorably in the media.
biote presently has a consensus target price of $8.11, suggesting a potential upside of 21.77%. AdTheorent has a consensus target price of $4.69, suggesting a potential upside of 46.94%. Given AdTheorent's higher possible upside, analysts clearly believe AdTheorent is more favorable than biote.
biote has a net margin of 4.30% compared to AdTheorent's net margin of -2.67%. AdTheorent's return on equity of 0.77% beat biote's return on equity.
21.7% of biote shares are held by institutional investors. Comparatively, 37.7% of AdTheorent shares are held by institutional investors. 13.9% of biote shares are held by insiders. Comparatively, 7.1% of AdTheorent shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
biote has higher revenue and earnings than AdTheorent. AdTheorent is trading at a lower price-to-earnings ratio than biote, indicating that it is currently the more affordable of the two stocks.
Summary
biote beats AdTheorent on 12 of the 18 factors compared between the two stocks.
Get biote News Delivered to You Automatically
Sign up to receive the latest news and ratings for BTMD and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BTMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
